152 related articles for article (PubMed ID: 36140469)
1. Bioinformatics Identification of TUBB as Potential Prognostic Biomarker for Worse Prognosis in ERα-Positive and Better Prognosis in ERα-Negative Breast Cancer.
Alhammad R
Diagnostics (Basel); 2022 Aug; 12(9):. PubMed ID: 36140469
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics Analysis of the Prognostic Significance of CAND1 in ERα-Positive Breast Cancer.
Alhammad R
Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36292029
[TBL] [Abstract][Full Text] [Related]
3. RUNX1T1, a potential prognostic marker in breast cancer, is co-ordinately expressed with ERα, and regulated by estrogen receptor signalling in breast cancer cells.
Saikia S; Pal U; Kalita DJ; Rai AK; Sarma A; Kataki AC; Limaye AM
Mol Biol Rep; 2021 Jul; 48(7):5399-5409. PubMed ID: 34264479
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
Zhang M; Chen H; Wang M; Bai F; Wu K
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis revealing prognostic significance of
Chen WX; Yang LG; Xu LY; Cheng L; Qian Q; Sun L; Zhu YL
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898978
[No Abstract] [Full Text] [Related]
6. TUBB, a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pan-cancer analysis.
Zhu Z; Zhang W; Huo S; Huang T; Cao X; Zhang Y
Front Mol Biosci; 2024; 11():1365655. PubMed ID: 38756529
[TBL] [Abstract][Full Text] [Related]
7. microRNA-Dependent Modulation of Genes Contributes to ESR1's Effect on ERα Positive Breast Cancer.
Gao S; Ding B; Lou W
Front Oncol; 2020; 10():753. PubMed ID: 32500028
[No Abstract] [Full Text] [Related]
8. Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy.
Zhu QN; Renaud H; Guo Y
Hereditas; 2018; 155():17. PubMed ID: 29371858
[TBL] [Abstract][Full Text] [Related]
9. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
10. Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients.
Nishimoto M; Nishikawa S; Kondo N; Wanifuchi-Endo Y; Hato Y; Hisada T; Dong Y; Okuda K; Sugiura H; Kato H; Takahashi S; Toyama T
Jpn J Clin Oncol; 2019 Jun; 49(6):567-575. PubMed ID: 30855679
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases.
Hoefnagel LD; Moelans CB; Meijer SL; van Slooten HJ; Wesseling P; Wesseling J; Westenend PJ; Bart J; Seldenrijk CA; Nagtegaal ID; Oudejans J; van der Valk P; van Gils CH; van der Wall E; van Diest PJ
Cancer; 2012 Oct; 118(20):4929-35. PubMed ID: 22415862
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
[TBL] [Abstract][Full Text] [Related]
14. Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer.
Su P; Hu J; Zhang H; Jia M; Li W; Jing X; Zhou G
Diagn Pathol; 2014 Jun; 9():119. PubMed ID: 24934762
[TBL] [Abstract][Full Text] [Related]
15. Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours.
Albergaria A; Paredes J; Sousa B; Milanezi F; Carneiro V; Bastos J; Costa S; Vieira D; Lopes N; Lam EW; Lunet N; Schmitt F
Breast Cancer Res; 2009; 11(3):R40. PubMed ID: 19549328
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
[TBL] [Abstract][Full Text] [Related]
17. Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer.
Xu L; Kwon YJ; Frolova N; Steg AD; Yuan K; Johnson MR; Grizzle WE; Desmond RA; Frost AR
Breast Cancer Res Treat; 2010 Aug; 123(1):59-71. PubMed ID: 19902354
[TBL] [Abstract][Full Text] [Related]
18. SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer.
Huo Q; Li Z; Cheng L; Yang F; Xie N
Front Oncol; 2020; 10():621. PubMed ID: 32528869
[No Abstract] [Full Text] [Related]
19. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer.
Yoshimoto N; Toyama T; Takahashi S; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
Breast Cancer Res Treat; 2011 Nov; 130(1):331-9. PubMed ID: 21755340
[TBL] [Abstract][Full Text] [Related]
20. Mining the prognostic significance of the GINS2 gene in human breast cancer using bioinformatics analysis.
Yu S; Zhu L; Xie P; Jiang S; Wang K; Liu Y; He J; Ren Y
Oncol Lett; 2020 Aug; 20(2):1300-1310. PubMed ID: 32724372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]